Skip to main content
Log in

Examining the costs of wet AMD in Europe

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Bandello F, Augustin A, Sahel J-A, Benhaddi H, Negrini C, Hieke K, Berdeaux GH, The MICMAC (MICro-economics of MACular degeneration) Study Group.Association between visual acuity and medical and non-medical costs in patients with wet age-related macular degeneration in France, Germany and Italy. Drugs and Aging 25: 255-268, No. 3, 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Examining the costs of wet AMD in Europe. Pharmacoecon. Outcomes News 550, 5 (2008). https://doi.org/10.2165/00151234-200805500-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805500-00009

Keywords

Navigation